Derivation Web

source_81033f29ed2348f2

**Selected angle:** `boundary_condition`

## One-sentence thesis

Across 4 independently cited sources, the evidence converges on one bounded claim: sGLT2 inhibitors reduce the risk of serious heart failure events and related cardiovascular composite outcomes in patients with type 2 diabetes and/or heart failure. Effect sizes vary by subgroup and are listed per source below rather than pooled into…